These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9690980)

  • 1. Effect of trifluoperazine, a potential drug for tuberculosis with psychotic disorders, on the growth of clinical isolates of drug resistant Mycobacterium tuberculosis.
    Gadre DV; Talwar V; Gupta HC; Murthy PS
    Int Clin Psychopharmacol; 1998 May; 13(3):129-31. PubMed ID: 9690980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of Mycobacterium tuberculosis strains to trifluoperazine.
    Gadre DV; Talwar V
    J Chemother; 1999 Jun; 11(3):203-6. PubMed ID: 10435682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates.
    Rey-Jurado E; Tudó G; de la Bellacasa JP; Espasa M; González-Martín J
    Int J Antimicrob Agents; 2013 Mar; 41(3):278-80. PubMed ID: 23312604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In Vitro Effect of Ankaferd Blood Stopper®, a Plant Extract Against Mycobacterium tuberculosis Isolates].
    Deveci A; Coban AY; Tanrıverdi Çaycı Y; Acicbe O; Taşdelen Fışgın N; Akgüneş A; Ozatlı D; Uzun M; Durupınar B
    Mikrobiyol Bul; 2013 Jan; 47(1):71-8. PubMed ID: 23390904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
    AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
    Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
    Parsons LM; Salfinger M; Clobridge A; Dormandy J; Mirabello L; Polletta VL; Sanic A; Sinyavskiy O; Larsen SC; Driscoll J; Zickas G; Taber HW
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2218-25. PubMed ID: 15917515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of anti-tuberculosis potential of siderophores against drug-resistant Mycobacterium tuberculosis by mycobacteria growth indicator tube-drug sensitivity test.
    Gokarn K; Pal RB
    BMC Complement Altern Med; 2017 Mar; 17(1):161. PubMed ID: 28327117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trifluoperazine and CEF-allicin from garlic (Allium sativum) as potential new antitubercular drugs active against drug resistantMycobacterium tuberculosis.
    Murthy PS; Ratnakar P; Gadre DV; Talwar V; Gupta HC; Gupta RL
    Indian J Clin Biochem; 1997 Dec; 12(Suppl 1):72-5. PubMed ID: 23100906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of crystal violet decolorization assay for minimal inhibitory concentration detection of primary antituberculosis drugs against Mycobacterium tuberculosis isolates.
    Coban AY; Akbal AU; Uzun M; Cayci YT; Birinci A; Durupinar B
    Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27304025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.
    Vesenbeckh S; Krieger D; Bettermann G; Schönfeld N; Bauer TT; Rüssmann H; Mauch H
    Tuberculosis (Edinb); 2016 May; 98():27-9. PubMed ID: 27156615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.